Drug Profile


Alternative Names: IBU-PC; Ibuprofen-PC; Ibuprofen-phosphatidylcholine; PL 1100; Zavryl

Latest Information Update: 31 Jul 2015

Price : $50

At a glance

  • Originator PLx Pharma
  • Class Antirheumatics; Antiulcers; Cytoprotectives; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylpropionates
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Inflammation; Pain

Most Recent Events

  • 31 Jul 2015 Preclinical trials in Pain and Inflammation (associated with osteoarthritis) in USA (PO)
  • 11 Jan 2011 Phase II development is ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top